Sonova Holding AG

Sonova Holding AG engages in the development and production of hearing care solutions. It operates through the Hearing Instruments and Cochlear Implants business segments. The Hearing Instruments segment includes the activities related to the design, development, production, distribution, and servicing of hearing instruments and related products. The Cochlear Implants segment involves the activities relevant to the design, development, production, distribution, and servicing of hearing implants and related products. The firm offers its products under the brands Phonak, Unitron, Hansaton, Connect Hearing, Boots Hearingcare, AudioNova, Geers, and Advanced Bionics. The company was founded in 1947 and is headquartered in Staefa, Switzerland.

Hologic

Investors interested in Medical - Instruments stocks are likely familiar with Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a better bang for their buck right now?

HOLX vs. SONVY: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Hologic (HOLX) or SONOVA HOLDING (SONVY). But which of these two companies is the best option for those looking for undervalued stocks?

HOLX or SONVY: Which Is the Better Value Stock Right Now?

Sonova Holding AG (OTCPK:SONVF) Q2 2024 Results Conference Call November 21, 2023 7:00 AM ET Company Participants Arnd Kaldowski - Chief Executive Officer Birgit Conix - Chief Financial Officer Thomas Bernhardsgrütter - Senior Director, IR Conference Call Participants Daniel Buchta - ZKB Al-Wakeel Hassan - Barclays Oliver Metzger - ODDO Hugo Solvet - BNP Paribas Veronika Dubajova - Citi Susannah Ludwig - Bernstein David Adlington - JPMorgan Urs Kunz - Research Partners Robert Davies - Morgan Stanley Falko Friedrichs - Deutsche Bank Maja Pataki - Kepler Cheuvreux Operator Ladies and gentlemen, welcome to the Sonova Holding AG Half Year Results 2023-'24 Conference Call and Live Webcast. I'm Sasha, the Chorus Call operator.

Sonova Holding AG (SONVF) Q2 2024 Earnings Call Transcript

Sonova has experienced a greater than expected hit to market share in the hearing aid market due to the loss of a major retail customer and price-driven market share loss. Sonova's margin performance has likewise come up short, leading to estimate cuts from sell-side analysts. There are opportunities for Sonova to regain momentum through new product offerings, expansion in China, and leveraging AI and machine learning technology in its high-end hearing aid business.

Sonova In A Growth And Margin Leverage Gully, But Valuation Makes It Worth Watching

Sonova Holding AG (OTCPK:SONVF) Q4 2023 Earnings Conference Call May 16, 2023 7:00 AM ET Company Participants Arnd Kaldowski - Chief Executive Officer Birgit Conix - Chief Financial Officer Thomas Bernhardsgrutter - Senior Director, IR Conference Call Participants Daniel Buchta - Zürcher Kantonalbank Christoph Gretler - Credit Suisse Daniel Jelovcan - Stifel Maja Pataki - Kepler Cheuvreux Julien Ouaddour - BofA Securities Hassan Al-Wakeel - Barclays Urs Kunz - Research Partners Veronika Dubajova - Citigroup Susannah Ludwig - Bernstein David Adlington - JPMorgan Arnd Kaldowski Good afternoon. Here in the room in Stäfa.

Sonova Holding AG (SONVF) Q4 2023 Earnings Call Transcript

Sonova has rebounded from its lows in recent months. The company is slowly pivoting more towards an omnichannel strategy.

Sonova: Omnichannel Strategy In The Hearing Aid Industry

Thermo Fisher Scientific

TMO vs. SONVY: Which Stock Is the Better Value Option?

Edwards Lifesciences

SONVY vs. EW: Which Stock Is the Better Value Option?

SONVY or EW: Which Is the Better Value Stock Right Now?

Hearing Care is a growing market that affects more people over time as our average life span increases. The sector has secular tailwinds and offers modest growth.

Sonova: Buy This Beneficiary Of An Aging Population

IDEXX Laboratories

SONVY vs. IDXX: Which Stock Is the Better Value Option?

SONVY or IDXX: Which Is the Better Value Stock Right Now?

Sonova is still logging core growth in the mid-single-digits, but management has acknowledged some pressures from weaker high-margin sales and higher input/fulfillment costs. Macro pressures could lead to consumers trading down or postponing hearing aid purchases in 2023/24, but Sonova's latest offering (Lumity) should drive share gains.

Sonova Seeing Strong Execution Collide With Macro Uncertainties

Sonova Holding AG (OTCPK:SONVF) Q2 2023 Earnings Conference Call November 14, 2022 7:00 AM ET Company Participants Arnd Kaldowski - Chief Executive Officer Birgit Conix - Chief Financial Officer Conference Call Participants Daniel Buchta - ZKB Hassan Al-Wakeel - Barclays Maja Pataki - Kepler Chris Gretler - Credit Suisse Julien Ouaddour - Bank of America Veronika Dubajova - Citi Graham Doyle - UBS Urs Kunz - Research Partners David Adlington - JPMorgan Falko Friedrichs - Deutsche Bank Daniel Jelovcan - Stifel Arnd Kaldowski Welcome to everybody on the call on this Monday afternoon. Thanks for your focus and attention and participation.

Sonova Holding AG (SONVF) Q2 2023 Earnings Call Transcript

Sonova Holding AG (OTCPK:SONVF) Q4 2022 Earnings Conference Call May 17, 2022 7:00 AM ET Company Participants Thomas Bernhardsgrütter - Director, Investor Relations Arnd Kaldowski - Chief Executive Officer Birgit Conix - Chief Financial Officer Conference Call Participants Daniel Buchta - ZKB Maja Pataki - Kepler David Adlington - J.P. Morgan Oliver Metzger - ODDO BHF Operator Ladies and gentlemen, welcome to the Sonova Holding AG Full-Year Results 2021/2022 Conference Call and Live Webcast.

Sonova Holding AG's (SONVF) CEO Arnd Kaldowski on Q4 2022 Results - Earnings Call Transcript

Accenture Plc

Orsted AS

Gilead Sciences

Medtronic

Companies with growing dividends can give you a buffer that prevents you from selling stocks in bad times.

7 Dividend Growth Stocks For 2022

Sonova Holding AG (SONVF) CEO Arnd Kaldowski on Q2 2022 Results - Earnings Call Transcript

If you are looking for stocks that are well positioned to maintain their recent uptrend, SONOVA HOLDING (SONVY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Here's Why Momentum in SONOVA HOLDING (SONVY) Should Keep going

SONOVA HOLDING (SONVY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

SONOVA HOLDING (SONVY) Is a Great Choice for "Trend" Investors, Here's Why

Sonova is one of the world's leaders in the hearing aid and cochlear implants business.

Sonova: An Expensive Call Option On An Aging Population

National Vision Hlds

Henry Schein

Maravai LifeSciences Holdings

These five MedTech stocks, EYE, MRVI, SONVY, SARTF and HSIC, all with a favorable Zacks Rank and growth parameters are expected to put up a robust performance in 2021.

News for Sonova Holding AG Stock (SONVY)